| Nadi Medical Group | |
|
4535 70th St La Mesa CA 91942-0701 | |
| (619) 750-4962 | |
| Not Available |
| Full Name | Nadi Medical Group |
|---|---|
| Speciality | Internal Medicine |
| Location | 4535 70th St, La Mesa, California |
| Authorized Official Name and Position | Masoud Nadi (OWNER/PRESIDENT) |
| Authorized Official Contact | 6196099492 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Nadi Medical Group 4535 70th St La Mesa CA 91942-0701 Ph: (619) 609-9294 | Nadi Medical Group 4535 70th St La Mesa CA 91942-0701 Ph: (619) 750-4962 |
| NPI Number | 1003523663 |
|---|---|
| Provider Enumeration Date | 11/03/2022 |
| Last Update Date | 03/30/2023 |
| Medicare PECOS PAC ID | 4082086129 |
|---|---|
| Medicare Enrollment ID | O20230217001775 |
News Archive
The Wait Time Alliance (WTA) today expressed disappointment that some jurisdictions have still not fulfilled their 2007 promise to implement wait time guarantees, and other jurisdictions have implemented guarantees that are inconsistent and weak.
The American Association of Critical-Care Nurses recently awarded its first $50,000 AACN Impact Research Grant to Ruth Kleinpell, PhD, RN-CS, FAAN, director, Center for Clinical Research, Rush University Medical Center, Chicago, and professor, Rush University College of Nursing.
Bayer HealthCare Pharmaceuticals Inc. announced today that its investigational compound regorafenib has been granted orphan drug status for the treatment of patients with gastrointestinal stromal tumors by the U.S. Food and Drug Administration.
After beginning treatment with remdesivir for COVID-19, a patient experienced significant bradycardia, or low heart rate. Her physicians used a dopamine infusion to stabilize her through the five-day course of remdesivir treatment, and her cardiac condition resolved itself at the end of the treatment.
Desuto, a leader in health and social care decision-support, has launched a unique new tool designed to transform the decision-making process for health and social care professionals across the UK.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003523663 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | (* (Not Available)) | Primary |
| 261QM2500X | Clinic/center - Medical Specialty | (* (Not Available)) | Secondary |
| Provider Name | Wahida Hamid |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1164812293 PECOS PAC ID: 5496076697 Enrollment ID: I20150529002249 |
News Archive
The Wait Time Alliance (WTA) today expressed disappointment that some jurisdictions have still not fulfilled their 2007 promise to implement wait time guarantees, and other jurisdictions have implemented guarantees that are inconsistent and weak.
The American Association of Critical-Care Nurses recently awarded its first $50,000 AACN Impact Research Grant to Ruth Kleinpell, PhD, RN-CS, FAAN, director, Center for Clinical Research, Rush University Medical Center, Chicago, and professor, Rush University College of Nursing.
Bayer HealthCare Pharmaceuticals Inc. announced today that its investigational compound regorafenib has been granted orphan drug status for the treatment of patients with gastrointestinal stromal tumors by the U.S. Food and Drug Administration.
After beginning treatment with remdesivir for COVID-19, a patient experienced significant bradycardia, or low heart rate. Her physicians used a dopamine infusion to stabilize her through the five-day course of remdesivir treatment, and her cardiac condition resolved itself at the end of the treatment.
Desuto, a leader in health and social care decision-support, has launched a unique new tool designed to transform the decision-making process for health and social care professionals across the UK.
› Verified 9 days ago
| Provider Name | Fahima Nadi |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1770072290 PECOS PAC ID: 7214275353 Enrollment ID: I20221110003037 |
News Archive
The Wait Time Alliance (WTA) today expressed disappointment that some jurisdictions have still not fulfilled their 2007 promise to implement wait time guarantees, and other jurisdictions have implemented guarantees that are inconsistent and weak.
The American Association of Critical-Care Nurses recently awarded its first $50,000 AACN Impact Research Grant to Ruth Kleinpell, PhD, RN-CS, FAAN, director, Center for Clinical Research, Rush University Medical Center, Chicago, and professor, Rush University College of Nursing.
Bayer HealthCare Pharmaceuticals Inc. announced today that its investigational compound regorafenib has been granted orphan drug status for the treatment of patients with gastrointestinal stromal tumors by the U.S. Food and Drug Administration.
After beginning treatment with remdesivir for COVID-19, a patient experienced significant bradycardia, or low heart rate. Her physicians used a dopamine infusion to stabilize her through the five-day course of remdesivir treatment, and her cardiac condition resolved itself at the end of the treatment.
Desuto, a leader in health and social care decision-support, has launched a unique new tool designed to transform the decision-making process for health and social care professionals across the UK.
› Verified 9 days ago
| Provider Name | Masoud Nadi |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1396259172 PECOS PAC ID: 8527430669 Enrollment ID: I20230217001867 |
News Archive
The Wait Time Alliance (WTA) today expressed disappointment that some jurisdictions have still not fulfilled their 2007 promise to implement wait time guarantees, and other jurisdictions have implemented guarantees that are inconsistent and weak.
The American Association of Critical-Care Nurses recently awarded its first $50,000 AACN Impact Research Grant to Ruth Kleinpell, PhD, RN-CS, FAAN, director, Center for Clinical Research, Rush University Medical Center, Chicago, and professor, Rush University College of Nursing.
Bayer HealthCare Pharmaceuticals Inc. announced today that its investigational compound regorafenib has been granted orphan drug status for the treatment of patients with gastrointestinal stromal tumors by the U.S. Food and Drug Administration.
After beginning treatment with remdesivir for COVID-19, a patient experienced significant bradycardia, or low heart rate. Her physicians used a dopamine infusion to stabilize her through the five-day course of remdesivir treatment, and her cardiac condition resolved itself at the end of the treatment.
Desuto, a leader in health and social care decision-support, has launched a unique new tool designed to transform the decision-making process for health and social care professionals across the UK.
› Verified 9 days ago
News Archive
The Wait Time Alliance (WTA) today expressed disappointment that some jurisdictions have still not fulfilled their 2007 promise to implement wait time guarantees, and other jurisdictions have implemented guarantees that are inconsistent and weak.
The American Association of Critical-Care Nurses recently awarded its first $50,000 AACN Impact Research Grant to Ruth Kleinpell, PhD, RN-CS, FAAN, director, Center for Clinical Research, Rush University Medical Center, Chicago, and professor, Rush University College of Nursing.
Bayer HealthCare Pharmaceuticals Inc. announced today that its investigational compound regorafenib has been granted orphan drug status for the treatment of patients with gastrointestinal stromal tumors by the U.S. Food and Drug Administration.
After beginning treatment with remdesivir for COVID-19, a patient experienced significant bradycardia, or low heart rate. Her physicians used a dopamine infusion to stabilize her through the five-day course of remdesivir treatment, and her cardiac condition resolved itself at the end of the treatment.
Desuto, a leader in health and social care decision-support, has launched a unique new tool designed to transform the decision-making process for health and social care professionals across the UK.
› Verified 9 days ago
Shota Gurtch, M.d., Inc., A Professional Corporation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 8875 La Mesa Blvd Ste C, La Mesa, CA 91942 Phone: 619-668-8100 | |
Michael Andrisani Md Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 8600 La Mesa Blvd, La Mesa, CA 91941 Phone: 619-469-3822 | |
Mohammed Miradi Md Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 5565 Grossmont Center Dr, Ste 211, La Mesa, CA 91942 Phone: 619-644-1483 | |
Encompass Family And Internal Medicine Group Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 7051 Alvarado Rd, 201, La Mesa, CA 91942 Phone: 619-460-7775 Fax: 858-519-5446 | |
Dap Health-la Mesa Pediatrics Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 8881 Fletcher Pkwy Ste 200, La Mesa, CA 91942 Phone: 619-464-6434 Fax: 619-464-5109 | |
Raed Al-naser, M.d., A Medical Corporation Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 5525 Grossmont Center Dr Ste 609, La Mesa, CA 91942 Phone: 619-589-9158 Fax: 619-462-0371 |